HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

RMD

ResMed Inc. (S&P 500)

Healthcare — Medical Instruments & Supplies

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Buy 2.3 / 5 17 analysts
$221.15
+$0.05 (+0.02%)
Target: $250.22 (13.1%)

Price History

52-Week Range
Sign in to add RMD to a watchlist or set price alerts.

Fundamentals

Market Cap$31.90B
P/E Ratio (TTM)21.18
Forward P/E16.72
EPS (TTM)$10.44
Dividend Yield1.19%
Profit Margin26.95%
Revenue Growth8.60%
ROE24.27%
Debt/Equity12.54
Recommendation Buy 2.3
Analyst Target$250.22
Analysts17
Next Earnings Aug 6, 2026 AMC
Indexes S&P 500

Technical Indicators

RSI (14)56.4
Beta0.77
SMA 20$223.47
SMA 40$226.02
52-Week High$284.87
52-Week Low$180.27
50-Day Avg$222.16
200-Day Avg$226.03
Avg Volume$1.41M
Volume902.5K

Performance Analysis

BULLISH

RMD shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 39% of its 52-week range.
+ RSI at 56.4 shows positive momentum.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
~ Modest revenue growth of 8.6% year-over-year.
+ Healthy profit margin of 26.9%.
+ Wall Street consensus is "Buy" from 17 analysts.
+ Average analyst target of $250.22 implies 13.1% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Oct 01, 2026 21:01 UTC

Back to Screener Export Report